Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2006070710PMID 17429054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The B7 family revisited.

  2005cited by this paper
• Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease.

  2005cited by this paper
• Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis.

  2005cited by this paper
• Key molecular events in puromycin aminonucleoside nephrosis rats

  2004cited by this paper
• Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome.

  2004cited by this paper
• Induction of B7-1 in podocytes is associated with nephrotic syndrome.

  2004cited by this paper
• The immune system in minimal change nephrotic syndrome

  2004cited by this paper
• Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome

  2004cited by this paper
• Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction.

  2004cited by this paper
• The role of podocytes in glomerular pathobiology

  2003cited by this paper
• Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome.

  2003cited by this paper
• Expression of nephrin, podocin, α-actinin, and WT1 in children with nephrotic syndrome

  2003cited by this paper
• Cell biology of the glomerular podocyte.

  2003cited by this paper
• Immune dysregulation in minimal change nephropathy.

  2003cited by this paper
• Truncation of C-mip (Tc-mip), a New Proximal Signaling Protein, Induces c-maf Th2 Transcription Factor and Cytoskeleton Reorganization

  2003cited by this paper
• Nephrin promotes cell-cell adhesion through homophilic interactions.

  2003cited by this paper
• HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.

  2003cited by this paper
• Childhood nephrotic syndrome in relapse is associated with down‐regulation of monocyte CD14 expression and lipopolysaccharide‐induced tumour necrosis factor‐α production

  2003cited by this paper
• Non‐viral transfer approaches for the gene therapy of mucopolysaccharidosis type II (Hunter syndrome)

  2002cited by this paper
• Differential expression of nephrin in acquired human proteinuric diseases.

  2002cited by this paper
• Podocyte-Associated Molecules in Puromycin Aminonucleoside Nephrosis of the Rat

  2002cited by this paper
• Expression of nephrin in acquired human glomerular disease.

  2002cited by this paper
• Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome.

  2002cited by this paper
• B7-1 (CD80) and B7-2 (CD 86) Expression in Human Tubular Epithelial Cells in vivo and in vitro1

  2002cited by this paper
• Tamarin alpha‐interferon is active in mouse liver upon intramuscular gene delivery

  2001cited by this paper
• Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.

  2001cited by this paper
• Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

  2001cited by this paper
• Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm.

  2001cited by this paper
• Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin.

  2001cited by this paper
• Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers.

  2001cited by this paper
• Interleukin 13: A Growth Factor in Hodgkin Lymphoma

  2001cited by this paper
• Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis.

  2000cited by this paper
• Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states.

  2000cited by this paper
• Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies.

  2000cited by this paper
• Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells.

  2000cited by this paper
• Nephrin in experimental glomerular disease.

  2000cited by this paper
• Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse.

  1999cited by this paper
• Interleukin 13 Is Secreted by and Stimulates the Growth of Hodgkin and Reed-Sternberg Cells

  1999cited by this paper
• Costimulatory regulation of T cell function.

  1999cited by this paper
• T-cell stimulation: an abundance of B7s

  1999cited by this paper
• Nephrin localizes to the slit pore of the glomerular epithelial cell.

  1999cited by this paper
• Structure and evolution of the extended B7 family.

  1999cited by this paper
• Agrin Is a High-affinity Binding Protein of Dystroglycan in Non-muscle Tissue*

  1998cited by this paper
• Involvement of interleukin (IL)‐13, but not IL‐4, in spontaneous IgE and IgG4 production in nephrotic syndrome

  1995cited by this paper
• Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix

  1992cited by this paper
• The hyperlipidemia of the nephrotic syndrome.

  1985cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Epidemiology and Classification Nephrotic Syndrome in Childhood

  year unknowncited by this paper

• B-cell activation underpins Rituximab response in focal segmental glomerulosclerosis.

  2026cites this paper
• Genetic and Iatrogenic Defects in Peripheral Tolerance Associated with Anti-Nephrin Antibody-Associated Minimal Change Disease

  2025cites this paper
• Impact of atopic dermatitis on renal dysfunction: insights from patient data and animal models

  2025cites this paper
• Novel inflammation biomarkers in adult minimal change disease: predicting steroid-resistance and relapse

  2025cites this paper
• Podocytopathies (Minimal Change Disease, Focal Segmental Glomerulosclerosis, and Idiopathic Nephrotic Syndrome of Childhood)

  2025cites this paper
• Immune dysregulation in pediatric cancer-associated nephrotic syndrome: current insights.

  2025cites this paper
• Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review

  2025cites this paper
• Unraveling the Immunogenetic Mechanisms of Childhood Idiopathic Nephrotic Syndrome.

  2025cites this paper
• Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study

  2025cites this paper
• Relation between interleukin-13 and annexin-V levels and carotid intima-media thickness in nephrotic syndrome

  2024cites this paper
• Glomerular Elastic Modulus and Gene Expression Patterns Define Two Phases of Alport Nephropathy

  2024cites this paper
• A patient with Behcet’s disease and IgA nephropathy in China

  2024cites this paper
• The Role of TNF-α in the Pathogenesis of Idiopathic Nephrotic Syndrome and Its Usefulness as a Marker of the Disease Course

  2024cites this paper
• A case report of minimal change disease associated with Kimura disease complicated by optic neuritis

  2024cites this paper
• The Pathogenesis of Nephrotic Syndrome: A Perspective from B Cells

  2024cites this paper
• Successful Treatment of Paraneoplastic Mesangioproliferative Glomerulonephritis in Mantle Cell Lymphoma Using Acalabrutinib and Rituximab

  2024cites this paper
• Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes

  2024cites this paper
• Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy

  2024cites this paper
• Canonical effects of cytokines on glomerulonephritis: A new outlook in nephrology

  2024cites this paper
• Detailed Pathophysiology of Minimal Change Disease: Insights into Podocyte Dysfunction, Immune Dysregulation, and Genetic Susceptibility

  2024cites this paper
• Swollen Feet: Considering the Paradoxical Roles of Interleukins in Nephrotic Syndrome

  2024influential citation
• Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis

  2023cites this paper
• A case of minimal change nephrotic syndrome complicated by Kimura disease treated with rituximab

  2023cites this paper
• Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target

  2023cites this paper
• Exploring the significance of interleukin-33/ST2 axis in minimal change disease

  2023cites this paper
• “Idiopathic” minimal change nephrotic syndrome: a podocyte mystery nears the end

  2023cites this paper
• The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease.

  2023cites this paper
• Case Report: The Application of Dupilumab in Atopic Dermatitis Children Complicated With Nephrotic Syndrome

  2022cites this paper
• Early, Noninvasive Clinical Indicators of Kidney Prognosis in Primary Nephrotic Syndrome: A Retrospective Exploratory Study

  2022cites this paper
• Vagus Nerve Stimulation: A Potential Therapeutic Role in Childhood Nephrotic Syndrome?

  2022cites this paper
• Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy

  2022cites this paper
• Acute Myeloid Leukemia in a Geriatric Patient with a History of Minimal Change Disease

  2022cites this paper
• Minimal change disease associated with gastrointestinal stromal tumor accompanied by significantly elevated serum IgE level: a case report

  2022cites this paper
• Transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of pediatric nephrotic syndrome: a pilot study

  2022cites this paper
• Paraneoplastic Glomerular Diseases.

  2022cites this paper
• The role of the immune system in idiopathic nephrotic syndrome

  2021cites this paper
• Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease

  2021cites this paper
• ROLE OF MONTELUKAST IN PREVENTING RELAPSE IN CHILDHOOD IDIOPATHIC NEPHROTIC SYNDROME: A QUASI-EXPERIMENTAL STUDY

  2021cites this paper
• Molecular Mechanisms of Proteinuria in Minimal Change Disease

  2021cites this paper
• SERUM LEVELS OF INTERLEUKINS 13 AND 17A IN IRAQI CHILDREN WITH NEPHROTIC SYNDROME

  2021cites this paper
• Atteintes rénales non liées aux immunoglobulines monoclonales au cours des hémopathies malignes et des thymomes

  2021cites this paper
• Spontaneous remission of minimal change nephrotic syndrome in an elderly man

  2021cites this paper
• Trends in pediatric nephrotic syndrome

  2021cites this paper
• Involvement of Hemopexin in the Pathogenesis of Proteinuria in Children with Idiopathic Nephrotic Syndrome

  2021cites this paper
• CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney Disease

  2021cites this paper
• B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement

  2021cites this paper
• Two faces of lupus nephritis? Answers

  2021cites this paper
• Parallel disease activity of Behçet’s disease with renal and entero involvements: a case report

  2021cites this paper
• The Effect of Interleukin-4 and Dexamethasone on RNA-Seq-Based Transcriptomic Profiling of Human Podocytes: A Potential Role in Minimal Change Nephrotic Syndrome

  2021cites this paper
• Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits

  2021cites this paper
• Steroid Minimization in Adults with Minimal Change Disease

  2021cites this paper
• Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy.

  2021cites this paper
• The Effect of Montelukast Sodium on the Reduction of Relapse Rates in Children with Steroid Dependent Nephrotic Syndrome

  2021cites this paper
• Primary Nephrotic Syndrome

  2020cites this paper
• Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes

  2020cites this paper
• MicroRNAs as Biomarkers for Nephrotic Syndrome

  2020cites this paper
• Paraneoplastic glomerulonephritis

  2020cites this paper
• Collapsing Focal Segmental Glomerulosclerosis

  2020cites this paper
• Interleukin-4 and Interleukin-13 Gene Polymorphisms in Children With Idiopathic Nephrotic Syndrome

  2020cites this paper
• Establishment of a novel nomogram for the clinically diagnostic prediction of minimal change disease, −a common cause of nephrotic syndrome

  2020cites this paper
• Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

  2020cites this paper
• Tumorbasierte Induktion von Glomerulonephritiden

  2020cites this paper
• Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders

  2020cites this paper
• IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease.

  2020cites this paper
• Podocytopathies

  2020cites this paper
• Several reasons for the development of proteinuria in nephrotic syndrome

  2020cites this paper
• Onconephrology: The intersections between the kidney and cancer

  2020cites this paper
• Summary of the International Conference on Onco-Nephrology: an emerging field in medicine.

  2019cites this paper
• Physiopathologie des syndromes néphrotiques idiopathiques

  2019cites this paper
• Minimal-change-Glomerulonephritis und fokal-segmentale Glomerulosklerose

  2019cites this paper
• Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle

  2019cites this paper
• Pathogenesis of Minimal Change Nephrotic Syndrome: A Review of the Underlying Molecular Mechanisms

  2019cites this paper
• Rituximab Use in the Management of Childhood Nephrotic Syndrome

  2019cites this paper
• Circulating Permeability Factors in Idiopathic Nephrotic Syndrome

  2019cites this paper
• Lupus Podocytopathy, Literature Review

  2019cites this paper
• [Idiopathic nephrotic syndrome: une Arlésienne?]

  2019cites this paper
• Paraneoplastic glomerular disease: The struggle is real

  2019cites this paper
• Podocytopathy with SLE: A Report of Two Cases

  2019cites this paper
• Glomerular Diseases Associated with Malignancies

  2019cites this paper
• Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects

  2019cites this paper
• Immunoglobulin E and G Levels in Predicting Minimal Change Disease before Renal Biopsy

  2018cites this paper
• Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in db/db Mice Using Cytokine Antibody Array

  2018cites this paper
• Therapies for Glomerular Diseases in Children

  2018cites this paper
• [Up to date of pathophysiology mechanism of idiopathic nephrotic syndromes: Minimal change disease and focal and segmental glomerulosclerosis].

  2018cites this paper
• Interaction of CD80 with Neph1: a potential mechanism of podocyte injury

  2018cites this paper
• Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease

  2018cites this paper
• Idiopathic Nephrotic Syndrome: Characteristics and Identification of Prognostic Factors

  2018cites this paper
• SERUM INTERLEUKIN 13 (IL-13) LEVELS IN IRAQI CHILDREN WITH NEPHROTIC SYNDROME.

  2018cites this paper
• miR-499 Ameliorates Podocyte Injury by Targeting Calcineurin in Minimal Change Disease

  2018cites this paper
• Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome

  2018cites this paper
• Chylous ascites and podocytopathy as the presentation of childhood lupus—an unusual occurrence

  2018cites this paper
• Interleukin-13 Increases Podocyte Apoptosis in Cultured Human Podocytes

  2018cites this paper
• Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome

  2018cites this paper
• Serum Interleukin 13 Level in Steroid Sensitive Nephrotic Syndrome

  2017cites this paper
• Advances and researches in idiopathic nephrotic syndrome biomarkers

  2017cites this paper
• Minimal Change Disease.

  2017cites this paper
• Elevation of plasma-soluble HLA-G in childhood nephrotic syndrome is associated with IgE

  2017cites this paper
• 7 Therapeutic Approach to Focal and Segmental Glomerulosclerosis ( FSGS ) Recurrence in Kidney Transplant Recipients

  2017cites this paper
• A case developing minimal change disease during the course of IgG4-related disease

  2017cites this paper
• Plasma exchange in kidney transplantation: Still a valuable option for nephrotic syndrome recurrence.

  2017cites this paper